Skip to main content
SpringerLink
Log in

Alternative Cancer Cures

  • Chapter
  • First Online:
So-Called Alternative Medicine (SCAM) for Cancer

  • 365 Accesses

Abstract

This chapter is dedicated to those forms of SCAM that are regularly being promoted as alternative cancer cures or treatments that prolong the life of cancer patients, i.e. SCAMs which are claimed to change the natural history of cancer. Changing the natural history means improving the prognosis either by eliminating the cancer completely or by slowing (or accelerating) cancer growth and thus prolonging (or shortening) the life of a cancer patient beyond the statistical average.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 37.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Croaker A, King GJ, Pyne JH, Anoopkumar-Dukie S, Liu L. A Review of Black Salve: Cancer Specificity, Cure, and Cosmesis. Evid Based Complement Alternat Med. 2017;2017:9184034. http://doi.org/10.1155/2017/9184034.

  2. 2.

    Ong NC, Sham E, Adams BM. Use of unlicensed black salve for cutaneous malignancy. Med J Aust. 2014;200(6):314. http://doi.org/10.5694/mja14.00041.

  3. 3.

    Saltzberg F, Barron G, Fenske N. Deforming self-treatment with herbal “black salve”. Dermatol Surg. 2009;35(7):1152–1154. http://doi.org/10.1111/j.1524-4725.2009.01206.x.

  4. 4.

    Lim A. Black salve treatment of skin cancer: a review. J Dermatolog Treat. 2018;29(4):388–392. http://doi.org/10.1080/09546634.2017.1395795.

  5. 5.

    Singh K, Jamshidi N, Zomer R, Piva TJ, Mantri N. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies. Int J Mol Sci. 2020;21(17):E6265. Published 2020 Aug 29. http://doi.org/10.3390/ijms21176265.

  6. 6.

    Singh Y, Bali C. Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation. Case Rep Oncol. 2013;6(3):585–592. Published 2013 Nov 28. http://doi.org/10.1159/000356446.

  7. 7.

    Abu-Amna M, Salti T, Khoury M, Cohen I, Bar-Sela G. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk? Curr Treat Options Oncol. 2021 Jan 13;22(2):16. http://doi.org/10.1007/s11864-020-00811-2. PMID: 33439370.

  8. 8.

    https://www.carctol.in/about.html.

  9. 9.

    Ernst E. Carctol: Profit before Patients?. Breast Care (Basel). 2009;4(1):31–33. http://doi.org/10.1159/000193025.

  10. 10.

    https://www.rfa.org/english/news/china/clinical-fakes-09272016141438.html.

  11. 11.

    Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ. 1999;319(7203):160–161. http://doi.org/10.1136/bmj.319.7203.160.

  12. 12.

    Li X, Yang G, Li X, et al. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in chinese, published correction appears in PLoS One. 2013;8(6). http://doi.org/10.1371/annotation/b53a0b8b-3eb6-44a2-9c37-bc9bb66bfe7e. PLoS One. 2013;8(4):e60338. http://doi.org/10.1371/journal.pone.0060338.

  13. 13.

    Li Y, Sui X, Su Z, et al. Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment. Front Pharmacol. 2020;11:132. Published 2020 Feb 27. http://doi.org/10.3389/fphar.2020.00132.

  14. 14.

    Lin S, An X, Guo Y, et al. Meta-Analysis of Astragalus-Containing Traditional Chinese Medicine Combined With Chemotherapy for Colorectal Cancer: Efficacy and Safety to Tumor Response. Front Oncol. 2019;9:749. Published 2019 Aug 13. http://doi.org/10.3389/fonc.2019.00749.

  15. 15.

    Zaidi A, Lai M, Cavenagh J. Long-term stabilisation of myeloma with curcumin. BMJ Case Rep. 2017;2017:bcr2016218148. Published 2017 Apr 16. http://doi.org/10.1136/bcr-2016-218148.

  16. 16.

    Choi YH, Han DH, Kim SW, et al. A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation. Prostate. 2019;79(6):614–621. http://doi.org/10.1002/pros.23766.

  17. 17.

    Saghatelyan T, Tananyan A, Janoyan N, et al. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial [published online ahead of print, 2020 Apr 18]. Phytomedicine. 2020;70:153218. http://doi.org/10.1016/j.phymed.2020.153218.

  18. 18.

    Cruz-Correa M, Hylind LM, Marrero JH, et al. Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis. Gastroenterology. 2018;155(3):668–673. http://doi.org/10.1053/j.gastro.2018.05.031.

  19. 19.

    Tas F, Cinar E, Erturk K. Complementary and alternative medicine (CAM) in Turkish cutaneous melanoma patients: A prospective study from tertiary cancer center. J Oncol Pharm Pract. 2021 Jan 12:1078155220987637. http://doi.org/10.1177/1078155220987637. Epub ahead of print. PMID: 33435821.

  20. 20.

    Chen X, Yu J, Zhong B, Lu J, Lu JJ, Li S, Lu Y. Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge. Pharmacol Res. 2019 July;145:104254. http://doi.org/10.1016/j.phrs.2019.104254. Epub 2019 May 1. PMID: 31054311.

  21. 21.

    Wang T, Fu X, Wang Z. Danshen Formulae for Cancer: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials. Evid Based Complement Alternat Med. 2019 Apr 2;2019:2310639. http://doi.org/10.1155/2019/2310639. PMID: 31061667; PMCID: PMC6466905.

  22. 22.

    https://edzardernst.com/2016/10/data-fabrication-in-china-is-an-open-secret/.

  23. 23.

    Wang X, Yang Y, Liu X, Gao X. Pharmacological properties of tanshinones, the natural products from Salvia miltiorrhiza. Adv Pharmacol. 2020;87:43–70. http://doi.org/10.1016/bs.apha.2019.10.001. Epub 2020 Jan 13. PMID: 32089238.

  24. 24.

    Essiac/Flor Essence (PDQ®) Patient Version, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Published online: December 11, 2015. https://www.ncbi.nlm.nih.gov/books/NBK66020/.

  25. 25.

    Ulbricht C, Weissner W, Hashmi S, et al. Essiac: systematic review by the natural standard research collaboration. J Soc Integr Oncol. 2009;7(2):73–80.

  26. 26.

    Milazzo S, Horneber M. Laetrile treatment for cancer. Cochrane Database Syst Rev. 2015;2015(4):CD005476. Published 2015 Apr 28. http://doi.org/10.1002/14651858.CD005476.pub4.

  27. 27.

    http://yestolife.org.uk/all_therapies.php.

  28. 28.

    Yau T, Dan X, Ng CC, Ng TB. Lectins with potential for anti-cancer therapy. Molecules. 2015 Feb 26;20(3):3791–810. http://doi.org/10.3390/molecules20033791. PMID: 25730388; PMCID: PMC6272365.

  29. 29.

    Ernst E, Schmidt K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer. 2003 Nov 1;107(2):262–7. http://doi.org/10.1002/ijc.11386. PMID: 12949804.

  30. 30.

    Mistletoe Extracts (PDQ®), Patient Version, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Published online: August 18, 2020.

  31. 31.

    Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD003297. http://doi.org/10.1002/14651858.CD003297.pub2. PMID: 18425885; PMCID: PMC7144832.

  32. 32.

    Jin X, Ruiz Beguerie J, Sze DM, Chan GC. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane Database Syst Rev. 2016 Apr 5;4(4):CD007731. http://doi.org/10.1002/14651858.CD007731.pub3. PMID: 27045603; PMCID: PMC6353236.

  33. 33.

    http://yestolife.org.uk/all_therapies.php.

  34. 34.

    Ernst E, Schmidt K. Ukrain. A new cancer cure? A systematic review of randomised clinical trials. BMC Cancer. 2005 July 1;5:69. http://doi.org/10.1186/1471-2407-5-69. PMID: 15992405; PMCID: PMC1180428.

  35. 35.

    https://www.hive.co.uk/Product/Professor-Edzard-Ernst/Homeopathy---The-Undiluted-Facts--Including-a-Comprehensive-A-Z-Lexicon/19719982.

  36. 36.

    Ernst E. Homeopathy: what does the “best” evidence tell us? Med J Aust. 2010 Apr 19;192(8):458–60. PMID: 20402610.

  37. 37.

    http://thehomeopathiccollege.org/cancer-treatment/homeopathy-effective-cancer-treatment/.

  38. 38.

    https://hpathy.com/homeopathy-interviews/dr-jens-wurster/.

  39. 39.

    https://cubamedicos.com/products/vidatox.

  40. 40.

    Giovannini C, Baglioni M, Baron Toaldo M, Cescon M, Bolondi L, Gramantieri L. Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma. Sci Rep. 2017 Mar 21;7:44685. http://doi.org/10.1038/srep44685. Erratum in: Sci Rep. 2017 Dec 22;7:46920. PMID: 28322221; PMCID: PMC5359575.

  41. 41.

    Khan S, Nayak D, Khurana A, Manchanda RK, Tandon C, Tandon S. In Vitro Assessment of Homeopathic Potencies of Hydrastis canadensis on Hormone-Dependent and Independent Breast Cancer. Homeopathy. 2020 July 1. http://doi.org/10.1055/s-0040-1709668. Epub ahead of print. PMID: 32610349.

  42. 42.

    Yadav R, Jee B, Rao KS. How homeopathic medicine works in cancer treatment: deep insight from clinical to experimental studies. J Exp Ther Oncol. 2019 Jan;13(1):71–76. PMID: 30658031.

  43. 43.

    Es S, Kuttan G, Kc P, Kuttan R. Effect of homeopathic medicines on transplanted tumors in mice. Asian Pac J Cancer Prev. 2007 July–Sept;8(3):390–4. PMID: 18159975.

  44. 44.

    Gaertner K, Müllner M, Friehs H, Schuster E, Marosi C, Muchitsch I, Frass M, Kaye AD. Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna. Complement Ther Med. 2014 Apr;22(2):320–32. http://doi.org/10.1016/j.ctim.2013.12.014. Epub 2014 Jan 8. PMID: 24731904.

  45. 45.

    Aust N. Prolonged lifetime by adjunct homeopathy in cancer patients-A case of immortal time bias. Complement Ther Med. 2016 Feb;24:80. http://doi.org/10.1016/j.ctim.2015.12.011. Epub 2015 Dec 30. PMID: 26860806.

  46. 46.

    Frass M, Lechleitner P, Gründling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmair M, Gaertner K, Duscheck C, Muchitsch I, Marosi C, Schumacher M, Zöchbauer-Müller S, Manchanda RK, Schrott A, Burghuber O. Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer: A Prospective, Randomized, Placebo-Controlled, Double-Blind, Three-Arm, Multicenter Study. Oncologist. 2020 Oct 3. http://doi.org/10.1002/onco.13548. Epub ahead of print. PMID: 33010094.

  47. 47.

    Kamiński M, Skonieczna-Żydecka K, Nowak JK, Stachowska E. Global and local diet popularity rankings, their secular trends, and seasonal variation in Google Trends data. Nutrition. 2020 Feb 12;79–80:110759. http://doi.org/10.1016/j.nut.2020.110759. Epub ahead of print. PMID: 32563767.

  48. 48.

    Psihogios A, Ennis JK, Seely D. Naturopathic Oncology Care for Pediatric Cancers: A Practice Survey. Integr Cancer Ther. 2019 Jan–Dec;18:1534735419878504. http://doi.org/10.1177/1534735419878504. PMID: 31566009; PMCID: PMC6769230.

  49. 49.

    Rinninella E, Mele MC, Cintoni M, Raoul P, Ianiro G, Salerno L, Pozzo C, Bria E, Muscaritoli M, Molfino A, Gasbarrini A. The Facts about Food after Cancer Diagnosis: A Systematic Review of Prospective Cohort Studies. Nutrients. 2020 Aug 5;12(8):2345. http://doi.org/10.3390/nu12082345. PMID: 32764484; PMCID: PMC7468771.

  50. 50.

    Ernst E, Cassileth B. Cancer diets, fads and facts. Cancer Prevent Int 1996; 2: 181–187.

  51. 51.

    https://www.acidalkalinediet.net/anti-cancer-diet.php.

  52. 52.

    Fenton TR, Huang T. Systematic review of the association between dietary acid load, alkaline water and cancer. BMJ Open. 2016 June 13;6(6):e010438. http://doi.org/10.1136/bmjopen-2015-010438. PMID: 27297008; PMCID: PMC4916623.

  53. 53.

    https://dr-barbara-hendel.com/en/nutrition/forms-of-nutrition/anthroposophical-diet/.

  54. 54.

    https://gerson.org/gerpress/.

  55. 55.

    Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol. 2010 Apr 20;28(12):2058–63. http://doi.org/10.1200/JCO.2009.22.8429. Epub 2009 Aug 17. PMID: 19687327; PMCID: PMC2860407.

  56. 56.

    Gerson Therapy (PDQ®) Health Professional Version, PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Published online: April 11, 2016. https://www.ncbi.nlm.nih.gov/books/NBK66029/.

  57. 57.

    Erickson N, Boscheri A, Linke B, Huebner J. Systematic review: isocaloric ketogenic dietary regimes for cancer patients. Med Oncol. 2017 May;34(5):72. http://doi.org/10.1007/s12032-017-0930-5. Epub 2017 Mar 28. PMID: 28353094.

  58. 58.

    Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019 Mar;22(2):129–134. http://doi.org/10.1097/MCO.0000000000000540. PMID: 30531479.

  59. 59.

    Cohen CW, Fontaine KR, Arend RC, Alvarez RD, Leath CA III, Huh WK, Bevis KS, Kim KH, Straughn JM Jr, Gower BA. A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer. J Nutr. 2018 Aug 1;148(8):1253–1260. http://doi.org/10.1093/jn/nxy119. PMID: 30137481.

  60. 60.

    Cohen CW, Fontaine KR, Arend RC, Soleymani T, Gower BA. Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial. Nutrients. 2018 Aug 30;10(9):1187. http://doi.org/10.3390/nu10091187. PMID: 30200193; PMCID: PMC6163837.

  61. 61.

    Kushi LH, Cunningham JE, Hebert JR, Lerman RH, Bandera EV, Teas J. The macrobiotic diet in cancer. J Nutr. 2001 Nov;131(11 Suppl):3056S–64S. http://doi.org/10.1093/jn/131.11.3056S. PMID: 11694648.

  62. 62.

    Lerman RH. The macrobiotic diet in chronic disease. Nutr Clin Pract. 2010 Dec;25(6):621–6. http://doi.org/10.1177/0884533610385704. PMID: 21139126.

  63. 63.

    Cunningham E, Marcason W. Is there any research to prove that a macrobiotic diet can prevent or cure cancer? J Am Diet Assoc. 2001 Sept;101(9):1030. http://doi.org/10.1016/S0002-8223(01)00253-X. PMID: 11573754.

  64. 64.

    Dinu M, Abbate R, Gensini GF, Casini A, Sofi F. Vegetarian, vegan diets and multiple health outcomes: A systematic review with meta-analysis of observational studies. Crit Rev Food Sci Nutr. 2017 Nov 22;57(17):3640–3649. http://doi.org/10.1080/10408398.2016.1138447. PMID: 26853923.

  65. 65.

    Tong TYN, Appleby PN, Armstrong MEG, Fensom GK, Knuppel A, Papier K, Perez-Cornago A, Travis RC, Key TJ. Vegetarian and vegan diets and risks of total and site-specific fractures: results from the prospective EPIC-Oxford study. BMC Med. 2020 Nov 23;18(1):353. http://doi.org/10.1186/s12916-020-01815-3. PMID: 33222682; PMCID: PMC7682057.

  66. 66.

    Huebner J, Marienfeld S, Abbenhardt C, Ulrich C, Muenstedt K, Micke O, Muecke R, Loeser C. Counseling patients on cancer diets: a review of the literature and recommendations for clinical practice. Anticancer Res. 2014 Jan;34(1):39–48. PMID: 24403443.

  67. 67.

    Abdel-Rahman O. Dietary Supplements Use among Adults with Cancer in the United States: A Population-Based Study. Nutr Cancer. 2020 Sept 15:1–8. http://doi.org/10.1080/01635581.2020.1820050. Epub ahead of print. PMID: 32930008.

  68. 68.

    Miller P, Demark-Wahnefried W, Snyder DC, Sloane R, Morey MC, Cohen H, Kranz S, Mitchell DC, Hartman TJ. Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv. 2008 Sept;2(3):138–48. http://doi.org/10.1007/s11764-008-0060-3. Epub 2008 July 11. PMID: 18792788; PMCID: PMC2766274.

  69. 69.

    https://www.essex.gov.uk/news.

  70. 70.

    Fung MC, Bowen DL. Silver products for medical indications: risk–benefit assessment. J Toxicol Clin Toxicol. 1996;34(1):119–26. http://doi.org/10.3109/15563659609020246. PMID: 8632503.

  71. 71.

    Keung YK, Wang T, Hong-Lung Hu E. Acute myeloid leukemia with complex cytogenetic abnormalities associated with long-term use of oral colloidal silver as nutritional supplement—Case report and review of literature. J Oncol Pharm Pract. 2020 Jan;26(1):212–215. http://doi.org/10.1177/1078155219832966. Epub 2019 Mar 9. PMID: 30854923.

  72. 72.

    Hadrup N, Lam HR. Oral toxicity of silver ions, silver nanoparticles and colloidal silver—a review. Regul Toxicol Pharmacol. 2014 Feb;68(1):1–7. http://doi.org/10.1016/j.yrtph.2013.11.002. Epub 2013 Nov 12. PMID: 24231525.

  73. 73.

    Mirsattari SM, Hammond RR, Sharpe MD, Leung FY, Young GB. Myoclonic status epilepticus following repeated oral ingestion of colloidal silver. Neurology. 2004 Apr 27;62(8):1408–10. http://doi.org/10.1212/01.wnl.0000120671.73335.ec. PMID: 15111684.

  74. 74.

    Leino V, Airaksinen R, Viluksela M, Vähäkangas K. Toxicity of colloidal silver products and their marketing claims in Finland. Toxicol Rep. 2020 Dec 26;8:106–113. http://doi.org/10.1016/j.toxrep.2020.12.021. PMID: 33437653; PMCID: PMC7786010.

  75. 75.

    Beuth J. Proteolytic enzyme therapy in evidence-based complementary oncology: fact or fiction? Integr Cancer Ther. 2008 Dec;7(4):311–6. http://doi.org/10.1177/1534735408327251. PMID: 19116226.

  76. 76.

    Sakalová A, Bock PR, Dedík L, Hanisch J, Schiess W, Gazová S, Chabronová I, Holomanova D, Mistrík M, Hrubisko M. Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma. Cancer Chemother Pharmacol. 2001 July;47 Suppl:S38–44. http://doi.org/10.1007/s002800170008. PMID: 11561871.

  77. 77.

    Kong X, Gao R, Wang Z, Wang X, Fang Y, Gao J, Reiter RJ, Wang J. Melatonin: A Potential Therapeutic Option for Breast Cancer. Trends Endocrinol Metab. 2020 Sept 3:S1043–2760(20)30155–7. http://doi.org/10.1016/j.tem.2020.08.001. Epub ahead of print. PMID: 32893084.

  78. 78.

    Samanta S. Melatonin: an endogenous miraculous indolamine, fights against cancer progression. J Cancer Res Clin Oncol. 2020 Aug;146(8):1893–1922. http://doi.org/10.1007/s00432-020-03292-w. Epub 2020 June 24. PMID: 32583237.

  79. 79.

    Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, Mills E. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 2012 Dec;11(4):293–303. http://doi.org/10.1177/1534735411425484. Epub 2011 Oct 21. PMID: 22019490.

  80. 80.

    Mills E, Wu P, Seely D, Guyatt G. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res. 2005 Nov;39(4):360–6. http://doi.org/10.1111/j.1600-079X.2005.00258.x. PMID: 16207291.

  81. 81.

    Wang YM, Jin BZ, Ai F, Duan CH, Lu YZ, Dong TF, Fu QL. The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol. 2012 May;69(5):1213–20. http://doi.org/10.1007/s00280-012-1828-8. Epub 2012 Jan 24. PMID: 22271210.

  82. 82.

    Pourhanifeh MH, Mehrzadi S, Kamali M, Hosseinzadeh A. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways. Eur J Pharmacol. 2020 Nov 5;886:173471. http://doi.org/10.1016/j.ejphar.2020.173471. Epub 2020 Aug 30. PMID: 32877658.

  83. 83.

    Iravani S, Eslami P, Dooghaie Moghadam A, Moazzami B, Mehrvar A, Hashemi MR, Mansour-Ghanaei F, Mansour-Ghanaei A, Majidzadeh-A K. The Role of Melatonin in Colorectal Cancer. J Gastrointest Cancer. 2020 Sept;51(3):748–753. http://doi.org/10.1007/s12029-019-00336-4. PMID: 31792737.

  84. 84.

    Fernández-Palanca P, Méndez-Blanco C, Fondevila F, Tuñón MJ, Reiter RJ, Mauriz JL, González-Gallego J. Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review. Antioxidants (Basel). 2021 Jan 12;10(1):E103. http://doi.org/10.3390/antiox10010103. PMID: 33445767.

  85. 85.

    Schmid D, Song M, Zhang X, Willett WC, Vaidya R, Giovannucci EL, Michels KB. Yogurt consumption in relation to mortality from cardiovascular disease, cancer, and all causes: a prospective investigation in 2 cohorts of US women and men. Am J Clin Nutr. 2020 Mar 1;111(3):689–697. http://doi.org/10.1093/ajcn/nqz345. PMID: 31968071; PMCID: PMC7049530.

  86. 86.

    https://www.wddty.com/news/2017/09/probiotics-could-reverse-colon-cancer.html?utm_source=Boomtrain&utm_medium=email&utm_campaign=enews_18092017&bt_ee=euUX7yQ7OOO6CU1n/e8H9k2OyIDolp+9Le03xGsYlQkq3y0NGSOt/xoJRRS2SCia&bt_ts=1505736085686.

  87. 87.

    Khani S, Hosseini HM, Taheri M, Nourani MR, Imani Fooladi AA. Probiotics as an alternative strategy for prevention and treatment of human diseases: a review. Inflamm Allergy Drug Targets. 2012 Apr;11(2):79–89. http://doi.org/10.2174/187152812800392832. PMID: 22280243.

  88. 88.

    Ostrander GK, Cheng KC, Wolf JC, Wolfe MJ. Shark cartilage, cancer and the growing threat of pseudoscience. Cancer Res. 2004 Dec 1;64(23):8485–91. http://doi.org/10.1158/0008-5472.CAN-04-2260. Erratum in: Cancer Res. 2005 Jan 1;65(1):374. PMID: 15574750.

  89. 89.

    Rabbani-Chadegani A, Abdossamadi S, Bargahi A, Yousef-Masboogh M. Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin. J Pharm Biomed Anal. 2008 Feb 13;46(3):563–7. http://doi.org/10.1016/j.jpba.2007.10.029. Epub 2007 Nov 1. PMID: 18093782.

  90. 90.

    Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP; North Central Cancer Treatment Group. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005 July 1;104(1):176–82. http://doi.org/10.1002/cncr.21107. PMID: 15912493.

  91. 91.

    Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 2010 July 7;5(7):e11414. http://doi.org/10.1371/journal.pone.0011414. PMID: 20628650; PMCID: PMC2898816.

  92. 92.

    Creagan ET, Moertel CG, O’Fallon JR, Schutt AJ, O’Connell MJ, Rubin J, Frytak S. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 1979 Sept 27;301(13):687–90. http://doi.org/10.1056/NEJM197909273011303. PMID: 384241.

  93. 93.

    Moertel CG, Fleming TR, Creagan ET, Rubin J, O’Connell MJ, Ames MM. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med. 1985 Jan 17;312(3):137–41. http://doi.org/10.1056/NEJM198501173120301. PMID: 3880867.

  94. 94.

    Ma Y, Chapman J, Levine M, Polireddy K, Drisko J, Chen Q. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med. 2014 Feb 5;6(222):222ra18. http://doi.org/10.1126/scitranslmed.3007154. PMID: 24500406.

  95. 95.

    Abdel-Latif MMM, Babar M, Kelleher D, Reynolds JV. A pilot study of the impact of Vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients. J Cancer Res Ther. 2019 Jan–Mar;15(1):185–191. http://doi.org/10.4103/jcrt.JCRT_763_16. PMID: 30880777.

  96. 96.

    Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist. 2015 Feb;20(2):210–23. http://doi.org/10.1634/theoncologist.2014-0381. Epub 2015 Jan 19. PMID: 25601965; PMCID: PMC4319640.

  97. 97.

    van Gorkom GNY, Lookermans EL, Van Elssen CHMJ, Bos GMJ. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review. Nutrients. 2019 Apr 28;11(5):977. http://doi.org/10.3390/nu11050977. PMID: 31035414; PMCID: PMC6566697.

  98. 98.

    Akutsu T, Kitamura H, Himeiwa S, Kitada S, Akasu T, Urashima M. Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer? Curr Oncol Rep. 2020 June 4;22(6):62. http://doi.org/10.1007/s11912-020-00929-4. PMID: 32495112.

  99. 99.

    Burzynski SR, Stolzmann Z, Szopa B, Stolzmann E, Kaltenberg OP. Antineoplaston A in cancer therapy. (I). Physiol Chem Phys. 1977;9(6):485–500. PMID: 275868.

  100. 100.

    Italian Study Group for the Di Bella Multitherapy Trials. Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails. BMJ. 1999 Jan 23;318(7178):224–8. PMID: 9915729; PMCID: PMC27702.

  101. 101.

    Di Bella G, Colori B, Mascia F. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas. Neuro Endocrinol Lett. 2012;33(8):773–81. PMID: 23391973.

  102. 102.

    Krege S, Hinke A, Otto T, Rübben H. Bewertung des Komplementärtherapeutikums Factor AF2 als Supportivum in der Behandlung des fortgeschrittenen Urothelkarzinoms. Prospektiv randomisierte Multicenterstudie [Evaluation of the complementary drug Factor AF2 as a supportive agent in management of advanced urothelial carcinoma. Prospective randomized multicenter study]. Urologe A. 2002 Mar;41(2):164–8. German. http://doi.org/10.1007/s001200100129. PMID: 11993095.

  103. 103.

    Chabot JA, Tsai WY, Fine RL, Chen C, Kumah CK, Antman KA, Grann VR. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol. 2010 Apr 20;28(12):2058–63. http://doi.org/10.1200/JCO.2009.22.8429. Epub 2009 Aug 17. PMID: 19687327; PMCID: PMC2860407.

  104. 104.

    PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. Gonzalez Regimen (PDQ®): Health Professional Version. 2018 Aug 22. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65848/.

  105. 105.

    Gold J. Use of hydrazine sulfate in terminal and preterminal cancer patients: results of investigational new drug (IND) study in 84 evaluable patients. Oncology. 1975;32(1):1–10. http://doi.org/10.1159/000225043. PMID: 1208024.

  106. 106.

    Kosty MP, Fleishman SB, Herndon JE 2nd, Coughlin K, Kornblith AB, Scalzo A, Morris JC, Mortimer J, Green MR. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol. 1994 June;12(6):1113–20. http://doi.org/10.1200/JCO.1994.12.6.1113. PMID: 8201372.

  107. 107.

    Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol. 1994 June;12(6):1126–9. http://doi.org/10.1200/JCO.1994.12.6.1126. PMID: 8201374.

  108. 108.

    Kaegi E. Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. CMAJ. 1998 May 19;158(10):1327–30. PMID: 9614826; PMCID: PMC1229327.

  109. 109.

    http://www.drkelley.com/CANLIVER55.html#_Toc434239866.

  110. 110.

    Smith MJ, Logan AC. Naturopathy. Med Clin North Am. 2002 Jan;86(1):173–84. http://doi.org/10.1016/s0025-7125(03)00079-8. PMID: 11795088.

  111. 111.

    Atwood KC 4th. Naturopathy: a critical appraisal. MedGenMed. 2003 Dec 30;5(4):39. PMID: 14745386.

  112. 112.

    Curr Oncol. 2019 Feb; 26(1): 12–18. Published online 2019 Feb 1. http://doi.org/10.3747/co.26.4815.

  113. 113.

    Psihogios A, Ennis JK, Seely D. Naturopathic Oncology Care for Pediatric Cancers: A Practice Survey. Integr Cancer Ther. 2019 Jan–Dec;18:1534735419878504. http://doi.org/10.1177/1534735419878504. PMID: 31566009; PMCID: PMC6769230.

  114. 114.

    http://www.gnmtherapy.co.uk/about-the-gnm/.

  115. 115.

    https://derstandard.at/2000043742380/18-Jaehrige-starbEltern-verweigerten-krebskranker-Tochter-Therapie.

  116. 116.

    http://www.powerlight-dubai.com/powerlight-ca.html.

  117. 117.

    https://medwatch.de/2020/05/15/warten-auf-ein-wunder/.

  118. 118.

    Baum M. An open letter to the Prince of Wales: with respect, your highness, you’ve got it wrong. BMJ 2004; 329:118.

Author information

Authors and Affiliations

  1. University of Exeter, Cambridge, UK

    Prof. Dr. Edzard Ernst

Authors
  1. Prof. Dr. Edzard Ernst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edzard Ernst .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ernst, E. (2021). Alternative Cancer Cures. In: So-Called Alternative Medicine (SCAM) for Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-74158-7_3

Download citation

Publish with us

Policies and ethics

Search

Navigation